Skip to main content

Thryv Holdings, Inc. (THRY)

Media and Entertainment Communication Services
Stock AI

Financial Metrics

Price to Earnings-5.71x
Revenue Growth (1Y)-6.16%
Debt to Equity1.15x

Strengths

Stock Chart

Valuation

Thryv Holdings, Inc. is overvalued

News

All
Press Releases
News
Filings
Thryv to Host Virtual Investor Product Demo for New Growth Platform on Aug. 6, 2026
August 04, 2026Thryv to Host Virtual Investor Product Demo for New Growth Platform on Aug. 6, 2026
Thryv and Ooma Announce Co-Marketing Agreement Targeting Small Businesses
August 04, 2026Thryv and Ooma Announce Co-Marketing Agreement Targeting Small Businesses
Thryv and Wix Announce Intent to Form Strategic Partnership to Power SMB Growth with Unified Commerce, Payments and Website Solutions
August 04, 2026Thryv and Wix Announce Intent to Form Strategic Partnership to Power SMB Growth with Unified Commerce, Payments and Website Solutions
Thryv Reports Second Quarter 2026 Results and Launches Thryv Growth Platform
August 04, 2026Thryv Reports Second Quarter 2026 Results and Launches Thryv Growth Platform
Thryv Launches AI-Native Growth Platform for Small Businesses
August 04, 2026Thryv Launches AI-Native Growth Platform for Small Businesses
10-Q Quarterly Report for 2026 Q2
August 04, 202610-Q Quarterly Report for 2026 Q2
Thryv Announces Integration with Breesy AI to Boost Growth for Franchise-Based Service Businesses
July 23, 2026Thryv Announces Integration with Breesy AI to Boost Growth for Franchise-Based Service Businesses
Thryv to Release Second Quarter 2026 Financial Results on Tuesday, August 4
July 21, 2026Thryv to Release Second Quarter 2026 Financial Results on Tuesday, August 4
Thryv Named to 2026 Top 100 Global Most Loved Workplaces List
July 14, 2026Thryv Named to 2026 Top 100 Global Most Loved Workplaces List
AI Adoption Continues to Rise, but 70% Say They Need More Training to Use It Effectively
July 09, 2026AI Adoption Continues to Rise, but 70% Say They Need More Training to Use It Effectively
 Thryv Therapeutics to Participate in UBS, RBC Capital Markets, and Jefferies Healthcare Conferences
May 12, 2026 Thryv Therapeutics to Participate in UBS, RBC Capital Markets, and Jefferies Healthcare Conferences
Thryv Grows SaaS Revenue in First Quarter 2026, Exceeds Total Company Revenue and EBITDA Guidance
April 30, 2026Thryv Grows SaaS Revenue in First Quarter 2026, Exceeds Total Company Revenue and EBITDA Guidance
10-Q Quarterly Report for 2026 Q1
April 30, 202610-Q Quarterly Report for 2026 Q1
 Thryv Therapeutics Commences Patient Dosing in Wave II Clinical Study for Long QT Syndrome and Receives FDA Fast Track Designation for THRV-1268
April 22, 2026 Thryv Therapeutics Commences Patient Dosing in Wave II Clinical Study for Long QT Syndrome and Receives FDA Fast Track Designation for THRV-1268
Thryv to Release First Quarter 2026 Financial Results on Thursday, April 30
April 09, 2026Thryv to Release First Quarter 2026 Financial Results on Thursday, April 30
Thryv Launches AI Lead Flow, Unifying Marketing and Sales Automation for Small Businesses
March 24, 2026Thryv Launches AI Lead Flow, Unifying Marketing and Sales Automation for Small Businesses
Thryv Achieves SaaS Revenue Growth of 34% in Full Year 2025, Shifts Focus to AI-Enabled "Market, Sell, Grow" Platform to Empower SMBs
February 26, 2026Thryv Achieves SaaS Revenue Growth of 34% in Full Year 2025, Shifts Focus to AI-Enabled "Market, Sell, Grow" Platform to Empower SMBs
10-K Annual Report for 2025 FY
February 26, 202610-K Annual Report for 2025 FY
Thryv to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26
February 03, 2026Thryv to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26
Cautious Optimism for 2026, but Uncertainty is High Among Small Businesses According to New Thryv Data
January 22, 2026Cautious Optimism for 2026, but Uncertainty is High Among Small Businesses According to New Thryv Data
 Thryv Therapeutics Launches Pivotal Wave II Phase 2/3 Study in Long QT Syndrome Type 2
January 13, 2026 Thryv Therapeutics Launches Pivotal Wave II Phase 2/3 Study in Long QT Syndrome Type 2
 Thryv Therapeutics Announces Positive Phase 1 Results of THRV-1268 in Obese Participants
December 17, 2025 Thryv Therapeutics Announces Positive Phase 1 Results of THRV-1268 in Obese Participants
Thryv Experts Share Top AI Trends That Will Drive Small Business Success in 2026
December 16, 2025Thryv Experts Share Top AI Trends That Will Drive Small Business Success in 2026
Price Over Earnings Overview: Thryv Holdings
December 10, 2025Price Over Earnings Overview: Thryv Holdings
 Thryv Therapeutics Strengthens Senior Leadership Team with Appointment of Matt Killeen, PhD, as Chief Business Officer
December 02, 2025 Thryv Therapeutics Strengthens Senior Leadership Team with Appointment of Matt Killeen, PhD, as Chief Business Officer
 Amy Rudolph, PhD, Joins Thryv Therapeutics' Board of Directors to Support Portfolio Progression into Heart Failure
November 19, 2025 Amy Rudolph, PhD, Joins Thryv Therapeutics' Board of Directors to Support Portfolio Progression into Heart Failure
 Thryv Therapeutics to Present at the 2025 American Heart Association Scientific Sessions in New Orleans, LA
November 05, 2025 Thryv Therapeutics to Present at the 2025 American Heart Association Scientific Sessions in New Orleans, LA
Thryv Introduces AI-Enabled Marketing Software for Home Services Businesses
November 04, 2025Thryv Introduces AI-Enabled Marketing Software for Home Services Businesses
 Thryv Therapeutics to Participate in Upcoming 2025 Healthcare Investor Conferences
November 03, 2025 Thryv Therapeutics to Participate in Upcoming 2025 Healthcare Investor Conferences
Thryv Grows SaaS Revenue 33% in Third Quarter 2025
October 30, 2025Thryv Grows SaaS Revenue 33% in Third Quarter 2025
10-Q Quarterly Report for 2025 Q3
October 30, 202510-Q Quarterly Report for 2025 Q3
Thryv to Release Third Quarter 2025 Financial Results on Thursday, October 30
October 07, 2025Thryv to Release Third Quarter 2025 Financial Results on Thursday, October 30
 Thryv Therapeutics Announces FDA IND Clearance of THRV-1268 for Long QT Syndrome
September 17, 2025 Thryv Therapeutics Announces FDA IND Clearance of THRV-1268 for Long QT Syndrome
SaaS Leader Sean Wechter Joins Thryv as Chief Technology Officer
September 09, 2025SaaS Leader Sean Wechter Joins Thryv as Chief Technology Officer
 Thryv Therapeutics Receives FDA IND Clearance of THRV-1268 for Clinical Programs in Heart Failure and Atrial Fibrillation and Presents Results of SGK1 Inhibition Combined with Jardiance (empagliflozin), an SGLT2 inhibitor, in a Pressure Overload Heart Failure Model at ESC Congress 2025
September 08, 2025 Thryv Therapeutics Receives FDA IND Clearance of THRV-1268 for Clinical Programs in Heart Failure and Atrial Fibrillation and Presents Results of SGK1 Inhibition Combined with Jardiance (empagliflozin), an SGLT2 inhibitor, in a Pressure Overload Heart Failure Model at ESC Congress 2025
10-Q Quarterly Report for 2025 Q2
July 30, 202510-Q Quarterly Report for 2025 Q2
10-Q Quarterly Report for 2025 Q1
May 01, 202510-Q Quarterly Report for 2025 Q1
Evogene Stock Soars After ICL Deal To Acquire Lavie Bio, MicroBoost AI
April 21, 2025Evogene Stock Soars After ICL Deal To Acquire Lavie Bio, MicroBoost AI
Top 3 Tech And Telecom Stocks You'll Regret Missing This Month
April 03, 2025Top 3 Tech And Telecom Stocks You'll Regret Missing This Month
10-K Annual Report for 2024 FY
February 27, 202510-K Annual Report for 2024 FY
10-Q Quarterly Report for 2024 Q3
November 07, 202410-Q Quarterly Report for 2024 Q3
10-Q Quarterly Report for 2024 Q2
August 01, 202410-Q Quarterly Report for 2024 Q2
10-Q Quarterly Report for 2024 Q1
May 02, 202410-Q Quarterly Report for 2024 Q1
10-K Annual Report for 2023 FY
February 22, 202410-K Annual Report for 2023 FY
10-Q Quarterly Report for 2023 Q3
November 02, 202310-Q Quarterly Report for 2023 Q3
10-Q Quarterly Report for 2023 Q2
August 03, 202310-Q Quarterly Report for 2023 Q2
10-Q Quarterly Report for 2023 Q1
May 04, 202310-Q Quarterly Report for 2023 Q1
10-K Annual Report for 2022 FY
February 23, 202310-K Annual Report for 2022 FY
10-Q Quarterly Report for 2022 Q3
November 03, 202210-Q Quarterly Report for 2022 Q3
10-Q Quarterly Report for 2022 Q2
August 04, 202210-Q Quarterly Report for 2022 Q2
10-Q Quarterly Report for 2022 Q1
May 05, 202210-Q Quarterly Report for 2022 Q1
10-K Annual Report for 2021 FY
March 15, 202210-K Annual Report for 2021 FY
10-Q Quarterly Report for 2021 Q3
November 12, 202110-Q Quarterly Report for 2021 Q3

A. Company Overview

Thryv Holdings, Inc. is a prominent player in the marketing and advertising sector, offering comprehensive solutions primarily targeting small and medium-sized businesses (SMBs) and emerging franchises. The company has established a significant presence with a legacy rooted in the marketing industry, providing a breadth of print and digital marketing solutions alongside a cloud-based software platform. Thryv serves approximately 350,000 SMB clients as of December 31, 2023, spread across four distinct business segments: Thryv U.S. Marketing Services, Thryv U.S. SaaS, Thryv International Marketing Services, and Thryv International SaaS.

In recent years, Thryv has actively pursued acquisitions to enhance its market presence and capabilities. Notable acquisitions include Yellow Holdings Limited in New Zealand, Vivial Media Holdings, Inc. in the United States, and Sensis Holding Limited in Australia. These strategic moves have broadened Thryv’s global footprint and expanded service offerings.

B. Business Segments

Thryv operates through four major segments, each contributing uniquely to the company’s overall revenue and strategic goals.

Thryv U.S. Marketing Services

This segment encompasses a range of print and digital marketing solutions tailored for the U.S. market. During the fiscal year ending December 31, 2023, Thryv U.S. Marketing Services generated $510.5 million in revenue. The primary offerings include:

  • Print Solutions: This includes the publication of Print Yellow Pages (PYPs) and White Pages, typically on a 15 to 18-month cycle. Advertisements in these directories are a core revenue stream.
  • Digital Solutions: Thryv also provides an Internet Yellow Pages (IYP) service through several online platforms (e.g., Yellowpages.com, Superpages.com). These platforms attract substantial traffic, facilitating ad placements and lead generation for SMB clients.

The U.S. marketing services are complemented by search engine marketing (SEM) solutions and a suite of additional digital media solutions, including social advertising and search engine optimization (SEO) tools.

Thryv U.S. SaaS

Thryv’s U.S. SaaS segment focuses on the flagship all-in-one small business management platform called Thryv®. This platform encompasses several integral components, including:

  • Command Center: A modular communication hub enabling businesses to centralize customer interactions across various channels, enhancing the customer relationship experience.
  • Business Center: This feature provides an end-to-end customer experience management toolkit, covering customer relationship management (CRM), appointment scheduling, invoicing, and more.
  • Marketing Center: A comprehensive marketing and advertising platform allowing SMBs to manage digital marketing campaigns, powered by AI-driven analytics to optimize performance.

The SaaS segment has been pivotal in generating recurring revenue streams through subscription contracts, presenting SMBs with customizable options tailored to their growth and operational needs.

Thryv International Marketing Services

This segment operates similarly to its U.S. counterpart but focuses on markets outside the United States, generating $142.7 million in revenue for the same fiscal year. Thryv’s international operations are designed to replicate successful marketing service structures adapted to local markets.

Thryv International SaaS

Thryv International SaaS extends its flagship platform to global markets, providing local businesses with access to the same suite of management tools available domestically.

C. Integration of Marketing Services and SaaS

Thryv’s strategy to combine its marketing services with its SaaS offerings is underpinned by a history of serving SMBs and responding to the increasing demand for integrated technology solutions. The seamless integration allows clients to streamline their business operations effectively, access customer insights, and optimize marketing efforts from a single platform.

D. Competitive Landscape

The landscape in which Thryv operates is characterized by intense competition and fragmentation. The company competes with various other firms providing marketing solutions and cloud-based SaaS tools tailored for SMBs. Key competitive factors include:

  • Customization and integration capabilities
  • Quality and pricing competitiveness
  • User-friendliness and brand recognition
  • Availability of customer support and onboarding programs

E. Strategic Initiatives

Thryv’s growth strategy is multifaceted, focusing on innovation, market penetration, and leveraging its sales force. The company aims to transition more clients from traditional marketing services to SaaS solutions while managing the revenue mix to ensure profitability amidst shifting industry dynamics.

Innovation and Development

Continuous enhancement of the Thryv platform is critical to retaining clients and fueling growth. Annual releases of new features and improvements ensure the platform meets evolving SMB needs. This is complemented by a significant focus on technology, ranging from custom software development to strategic partnerships designed to amplify the platform's capabilities.

Acquisitions and International Expansion

Thryv is keen on pursuing opportunistic acquisitions to drive synergy and scale, having historically realized cost efficiencies and new client opportunities through past acquisitions. The company also highlights international growth as a strategic focus, with plans to expand into new markets through various mechanisms, including direct sales and partnerships.

Stock Infos

SectorCommunication Services
IndustryMedia and Entertainment
CEOJoseph A. Walsh

Dividends

Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.